IGM Biosciences Inc.

NASDAQ: IGMS · Real-Time Price · USD
1.27
0.00 (0.00%)
At close: Aug 13, 2025, 3:59 PM
1.28
0.79%
After-hours: Aug 13, 2025, 06:49 PM EDT

IGM Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-53.38M -198.87M -195.79M -219.84M -220.4M -236.92M -246.42M -238.3M -234.34M -228.52M -221.1M -219.17M -205.29M -185.41M -165.16M -139.14M -115.25M -95.38M
Depreciation & Amortization
7.37M 9.21M 9.11M 8.94M 8.89M 8.79M 8.28M 7.99M 7.24M 6.51M 6.08M 5.48M 5.07M 5.04M 4.48M 3.49M 2.65M 1.48M
Stock-Based Compensation
30.12M 35.83M 38.27M 41.79M 37.54M 43.42M 46.55M 48.42M 47.28M 44.26M 44.71M 42.15M 37.55M 31.87M 25.87M 19.91M 16.29M 12.63M
Other Working Capital
-10.64M -10.73M -6.52M -174K 366K -4.79M -5.7M -8.82M -9.19M 151.25M 158.17M 162.19M 161.34M 10.88M 5.79M -1.34M -3.39M -5.61M
Other Non-Cash Items
-128.17M 37.86M 25.66M 43.1M 47.71M 36.2M 26.84M 12.19M 8.9M 8.67M 9.29M 6.79M 5.67M 3.73M 3.24M 3.01M 2.79M 2.59M
Deferred Income Tax
n/a n/a n/a -16.12M -18.47M -20.78M -20.78M -4.66M -2.31M n/a n/a 295K 449K 586K 781K 690K 667K 478K
Change in Working Capital
-12.45M -13.34M -6.83M -643K 220K -4.74M -6.69M -7.72M -9.14M 151.09M 155.17M 161.56M 159.26M 9.24M 6.45M -152K 402K -986K
Operating Cash Flow
-156.51M -143.1M -153M -166.18M -167.92M -183.65M -192.23M -182.08M -182.37M -17.98M -5.85M -2.9M 2.69M -134.95M -124.34M -112.19M -92.45M -79.18M
Capital Expenditures
-2.19M -3.4M -5.85M -6.44M -8.23M -10.93M -12.38M -13.63M -13.26M -11.17M -10.21M -9.27M -8.81M -10.15M -13.24M -18.19M -22.51M -21.87M
Cash Acquisitions
-32K n/a n/a 13.24M -9.36M -6.97M -6.97M -12.85M 10.82M 190.56M 190.56M 183.2M 182.16M n/a n/a -57.71M -57.71M -57.71M
Purchase of Investments
-118.89M -179.87M -219.43M -272.62M -316.38M -330.55M -365.04M -433.87M -423.2M -589.15M -540.02M -399.62M -363.2M -156.5M -129.35M -156.18M -129.92M -180.42M
Sales Maturities Of Investments
236.65M 280.67M 289.4M 310.49M 362.6M 348.66M 445.77M 511.73M 477.4M 463.62M 324.58M 203.91M 124.07M 122.74M 157.41M 207.99M 244.24M 271.08M
Other Investing Acitivies
2.72M 26.57M 24.64M 11.4M 33.99M 5.84M 6.97M 12.85M -10.82M -190.56M -206.69M -195.32M -239.15M -33.1M 28.7M 82.41M 145.33M 121.02M
Investing Cash Flow
118.26M 98.24M 64.16M 31.47M 38.03M 7.18M 68.36M 64.24M 40.94M -136.7M -225.64M -204.99M -247.94M -43.92M 14.82M 33.62M 91.8M 68.79M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
1K n/a n/a n/a -1K n/a n/a n/a n/a n/a n/a -137K -540K -1.14M -1.55M -1.42M -1.94M -1.91M
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
1.64M 2.24M 2.39M 2.37M 1.19M 70.53M 70.45M 70.53M 70.81M 219.38M 219.38M 220.39M 221.16M 2.6M 2.48M 709K -1.28M -1.48M
Financial Cash Flow
1.64M 2.24M 2.39M 2.37M 45.81M 115.14M 115.07M 115.15M 70.81M 219.38M 219.38M 220.39M 221.16M 2.6M 2.48M 216.9M 214.91M 214.71M
Net Cash Flow
-36.61M -42.61M -86.45M -132.35M -84.08M -61.32M -8.81M -2.7M -70.63M 64.71M -12.12M 12.5M -24.08M -176.26M -107.05M 138.32M 214.26M 204.32M
Free Cash Flow
-158.7M -146.5M -158.85M -172.62M -176.15M -194.58M -204.61M -195.71M -195.63M -29.15M -16.06M -12.18M -6.12M -145.09M -137.58M -130.38M -114.96M -101.05M